Viewing Study NCT00828594

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 1:41 AM

Ignite Modification Date: 2025-12-26 @ 2:03 AM

Study NCT ID: NCT00828594

Status: TERMINATED

Last Update Posted: 2013-04-11

First Post: 2009-01-09

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

Sponsor: Novartis Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module